<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01275027</url>
  </required_header>
  <id_info>
    <org_study_id>ARI-1340-Nutralin</org_study_id>
    <nct_id>NCT01275027</nct_id>
  </id_info>
  <brief_title>A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin</brief_title>
  <official_title>A Phase II, Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avera McKennan Hospital &amp; University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avera McKennan Hospital &amp; University Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical research study is to evaluate the effects an investigational
      food product has on the blood sugar and insulin levels in individuals with diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigational product has helped decrease the amount of insulin needed in treating
      diabetic dogs and has improved the dogs' longevity and quality of life. Observational
      analysis by trained veterinarians has indicated that the natural fluctuations in blood
      glucose levels do not exist in dogs consuming the product. An initial Phase 1 study tested
      the product in a brownie form. The product has been reformulated to capsule form for the
      Phase 2 study.

      The hypothesis for this study is that diabetic individuals will decrease their
      insulin/diabetic medication usage and have a decrease in glucose levels after consuming the
      product for 16 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Sponsor recalled the study
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Sugar</measure>
    <time_frame>16 weeks</time_frame>
    <description>blood sugar levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HgA1c reduction</measure>
    <time_frame>16 weeks</time_frame>
    <description>reduction of Hemoglobin A1c levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes medication</measure>
    <time_frame>16 weeks</time_frame>
    <description>reduction in the amount of diabetes medication needed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Nutralin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals with Type 2 Diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Individuals with Type 2 Diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutralin</intervention_name>
    <description>7 capsules taken 15 minutes before each of the three main meals of the day</description>
    <arm_group_label>Nutralin</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women who are at least 18 years old

          -  Diagnosis of Type 2 Diabetes

          -  Has been on stable diabetes medication/insulin for the past three months

        Exclusion Criteria:

          -  Women who are pregnant, breastfeeding or planning to become pregnant

          -  Diagnosis of Celiac Disease or gluten intolerance

          -  Current or active kidney disease

          -  Current or active liver disease

          -  Any food allergies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Zawada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Avera McKennan Hospital &amp; University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Avera Research Institute</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.avera-research.org</url>
    <description>Avera Research Institute website</description>
  </link>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2011</study_first_submitted>
  <study_first_submitted_qc>January 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2011</study_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>blood sugar</keyword>
  <keyword>insulin</keyword>
  <keyword>nutritional supplement</keyword>
  <keyword>nutraceutical</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

